These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 25450398)

  • 41. Focal adhesion kinase controls prostate cancer progression via intrinsic kinase and scaffolding functions.
    Figel S; Gelman IH
    Anticancer Agents Med Chem; 2011 Sep; 11(7):607-16. PubMed ID: 21355844
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gene Editing of α6 Integrin Inhibits Muscle Invasive Networks and Increases Cell-Cell Biophysical Properties in Prostate Cancer.
    Rubenstein CS; Gard JMC; Wang M; McGrath JE; Ingabire N; Hinton JP; Marr KD; Simpson SJ; Nagle RB; Miranti CK; Warfel NA; Garcia JGN; Arif-Tiwari H; Cress AE
    Cancer Res; 2019 Sep; 79(18):4703-4714. PubMed ID: 31337652
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro and in vivo effects of short hairpin RNA targeting integrin-linked kinase in prostate cancer cells.
    Yuan Y; Xiao Y; Li Q; Liu Z; Zhang X; Qin C; Xie J; Wang X; Xu T
    Mol Med Rep; 2013 Aug; 8(2):419-24. PubMed ID: 23783575
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
    Hildenbrand R; Schaaf A
    Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CFTR suppresses tumor progression through miR-193b targeting urokinase plasminogen activator (uPA) in prostate cancer.
    Xie C; Jiang XH; Zhang JT; Sun TT; Dong JD; Sanders AJ; Diao RY; Wang Y; Fok KL; Tsang LL; Yu MK; Zhang XH; Chung YW; Ye L; Zhao MY; Guo JH; Xiao ZJ; Lan HY; Ng CF; Lau KM; Cai ZM; Jiang WG; Chan HC
    Oncogene; 2013 May; 32(18):2282-91, 2291.e1-7. PubMed ID: 22797075
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Urokinase receptors promote beta1 integrin function through interactions with integrin alpha3beta1.
    Wei Y; Eble JA; Wang Z; Kreidberg JA; Chapman HA
    Mol Biol Cell; 2001 Oct; 12(10):2975-86. PubMed ID: 11598185
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Integrin α6/Akt/Erk signaling is essential for human breast cancer resistance to radiotherapy.
    Hu T; Zhou R; Zhao Y; Wu G
    Sci Rep; 2016 Sep; 6():33376. PubMed ID: 27624978
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Involvement of β1-integrin via PIP complex and FAK/paxillin in dexamethasone-induced human mesenchymal stem cells migration.
    Yun SP; Ryu JM; Han HJ
    J Cell Physiol; 2011 Mar; 226(3):683-92. PubMed ID: 20717960
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity. EGF-receptor inhibition may prevent tumor cell dissemination.
    Festuccia C; Angelucci A; Gravina GL; Biordi L; Millimaggi D; Muzi P; Vicentini C; Bologna M
    Thromb Haemost; 2005 May; 93(5):964-75. PubMed ID: 15886816
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of urokinase-type plasminogen activator receptor induces apoptosis in melanoma cells by activation of p53.
    Besch R; Berking C; Kammerbauer C; Degitz K
    Cell Death Differ; 2007 Apr; 14(4):818-29. PubMed ID: 17110957
    [TBL] [Abstract][Full Text] [Related]  

  • 51. uPAR/cathepsin B overexpression reverse angiogenesis by rescuing FAK phosphorylation in uPAR/cathepsin B down regulated meningioma.
    Gupta R; Nalla AK; Gogineni VR; Chetty C; Bhoopathi P; Klopfenstein JD; Tsung AJ; Mohanam S; Rao JS
    PLoS One; 2011 Feb; 6(2):e17123. PubMed ID: 21347260
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Effect of integrin-linked kinase on the growth of prostate cancer in nude mice].
    Li Q; Xu T; He PY; Hao YC; Wang XF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2010 Aug; 42(4):374-80. PubMed ID: 20721246
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Aspirin inhibits highly invasive prostate cancer cells.
    Lloyd FP; Slivova V; Valachovicova T; Sliva D
    Int J Oncol; 2003 Nov; 23(5):1277-83. PubMed ID: 14532966
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A critical role of integrin-linked kinase, ch-TOG and TACC3 in centrosome clustering in cancer cells.
    Fielding AB; Lim S; Montgomery K; Dobreva I; Dedhar S
    Oncogene; 2011 Feb; 30(5):521-34. PubMed ID: 20838383
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Twist induces epithelial-mesenchymal transition and cell motility in breast cancer via ITGB1-FAK/ILK signaling axis and its associated downstream network.
    Yang J; Hou Y; Zhou M; Wen S; Zhou J; Xu L; Tang X; Du YE; Hu P; Liu M
    Int J Biochem Cell Biol; 2016 Feb; 71():62-71. PubMed ID: 26693891
    [TBL] [Abstract][Full Text] [Related]  

  • 56. C-reactive protein binds to integrin α2 and Fcγ receptor I, leading to breast cell adhesion and breast cancer progression.
    Kim ES; Kim SY; Koh M; Lee HM; Kim K; Jung J; Kim HS; Moon WK; Hwang S; Moon A
    Oncogene; 2018 Jan; 37(1):28-38. PubMed ID: 28846105
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Overexpression of the urokinase receptor mRNA splice variant uPAR-del4/5 affects tumor-associated processes of breast cancer cells in vitro and in vivo.
    Sato S; Kopitz C; Grismayer B; Beaufort N; Reuning U; Schmitt M; Luther T; Kotzsch M; Krüger A; Magdolen V
    Breast Cancer Res Treat; 2011 Jun; 127(3):649-57. PubMed ID: 20635136
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Suppression of FOXQ1 in benzyl isothiocyanate-mediated inhibition of epithelial-mesenchymal transition in human breast cancer cells.
    Sehrawat A; Kim SH; Vogt A; Singh SV
    Carcinogenesis; 2013 Apr; 34(4):864-73. PubMed ID: 23276794
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Targeting MMP-9, uPAR, and cathepsin B inhibits invasion, migration and activates apoptosis in prostate cancer cells.
    Nalla AK; Gorantla B; Gondi CS; Lakka SS; Rao JS
    Cancer Gene Ther; 2010 Sep; 17(9):599-613. PubMed ID: 20448670
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of urokinase plasminogen activator receptor in thrombospondin 1-mediated tumor cell invasion.
    Albo D; Berger DH; Rothman VL; Tuszynski GP
    J Surg Res; 1999 Apr; 82(2):331-8. PubMed ID: 10090848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.